Skip to content

Vir Biotechnology, Inc. VIR Investment Purchases

Investment Purchases at other companies

Gilead Sciences logo
Gilead SciencesGILD
$525M
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$91.32M+28.2%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$56M-42.8%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$139.09M+138,993%
Biohaven logo
BiohavenBHVN
$19.79M-55.7%
Moderna logo
ModernaMRNA
$1.35B-23.6%

Other financials

Income statement

See full
Revenue-$29.0K-101%
Gross profit$1.2M-60.2%
Operating income-$132.3M+5.2%
Net income-$125.7M-3.9%
EPS (diluted)-$0.85+3.4%

Balance sheet

See full
Cash & equivalents$283.0M-23.1%
Total debt$95.6M-0.5%
Total equity$812.8M-22.1%
Total assets$1.0B-21.6%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$390.0K-76.1%
Free cash flow-$132.8M-66.5%

Valuation

See full
Market cap$1.71B+61.1%
Enterprise value$1.53B+102%
P/S26.2×-24.8×

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-720.8%-313pp
Net margin-676%-291pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-47.7%+3.6pp
Debt / equity0.1×0.0×
Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s investment purchases?
Vir Biotechnology, Inc. (VIR) reported investment purchases of $158.37M in Q1 2026.
How has Vir Biotechnology, Inc.'s investment purchases changed year-over-year?
Vir Biotechnology, Inc.'s investment purchases decreased by 8.8% year-over-year, from $173.69M to $158.37M.
What is the long-term trend for Vir Biotechnology, Inc.'s investment purchases?
Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s investment purchases has grown at a 20.5% compound annual growth rate (CAGR), from $420.24M to $886.33M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.